A Dose Increase Finding Study of Doxorubicin Hydrochloride Liposome Injection for Patients With Breast Cancer

The requested reference [9c5a66a7d4cfb5c78ab711fba8f4380a0c6779f4] no longer exists in our database. It has been replaced by the current reference: [48c6226adbc0071a3981449d659ad22c5143cb9f]

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2017
To study the maximum tolerated dose of Doxorubicin Hydrochloride Liposome Injection combination with cyclophosphamide and sequential treatment of docetaxel for patients with locally advanced breast cancer
Epistemonikos ID: 99b5f9248139ae0384c62eafabdaa2b45e156acf
First added on: May 20, 2024